company background image
FLRY3 logo

Fleury Informe acción BOVESPA:FLRY3

Último precio

R$13.54

Capitalización de mercado

R$7.5b

7D

-3.0%

1Y

-20.6%

Actualizada

18 Nov, 2024

Datos

Finanzas de la empresa +

Fleury S.A.

Informe acción BOVESPA:FLRY3

Capitalización de mercado: R$7.5b

Resumen de acción FLRY3

Fleury S.A., junto con sus filiales, presta servicios médicos en las áreas de diagnóstico, tratamiento, análisis clínicos, gestión sanitaria, asistencia médica, ortopedia y oftalmología en Brasil. Saber más

Análisis fundamental de FLRY3
Puntuación del snowflake
Valoración5/6
Crecimiento futuro2/6
Rendimiento pasado5/6
Salud financiera4/6
Dividendos4/6

Recompensas

Cotiza un 36.3% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los beneficios de 13.82%

Los beneficios aumentaron un 64.3% el pasado año

Los analistas coinciden en que el precio de las acciones subirá un 41%

Análisis de riesgos

Historial de dividendos inestable


Competidores de Fleury S.A.

Oncoclínicas do Brasil Serviços Médicos

BOVESPA:ONCO3

R$2.5b

Odontoprev

BOVESPA:ODPV3

R$5.6b

Rede D'Or São Luiz

BOVESPA:RDOR3

R$66.1b

Profarma Distribuidora de Produtos Farmacêuticos

BOVESPA:PFRM3

R$864.4m

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Fleury
Precios históricos de las acciones
Precio actual de la acciónR$13.54
Máximo en las últimas 52 semanasR$18.96
Mínimo de 52 semanasR$13.46
Beta0.60
1Cambio en 1 mes-9.25%
Variación en 3 meses-14.52%
Cambio de 1 año-20.63%
3Variación en 3 años-24.01%
Variación en 5 años-50.06%
Variación desde la OPV55.80%

Noticias y actualizaciones recientes

We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Nov 15
We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 02
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Sep 26
Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Recent updates

We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Nov 15
We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 02
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Sep 26
Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Jun 18
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Apr 16
The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Mar 14
Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Jan 05
Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Oct 05
Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Jun 27
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Feb 25
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Sep 26
At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Sep 08
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

Jul 01
Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

When Should You Buy Fleury S.A. (BVMF:FLRY3)?

Jun 10
When Should You Buy Fleury S.A. (BVMF:FLRY3)?

Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Apr 10
Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

Mar 24
Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Feb 08
At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Dec 08
Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 05
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Oct 21
Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Aug 24
Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Jul 31
Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Jul 07
Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Apr 30
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

Apr 12
Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Mar 29
At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Mar 16
Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Mar 01
Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 28
Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Feb 15
What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Feb 02
Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Jan 03
Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Dec 28
Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Dec 12
Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Nov 29
Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Aug 30
Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Aug 18
Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

Aug 03
Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

Rentabilidad de los accionistas

FLRY3BR HealthcareMercado BR
7D-3.0%0.3%-0.06%
1Y-20.6%-13.6%-1.6%

Rentabilidad vs. Industria: Los resultados de FLRY3 fueron inferiores a los de la industria BR Healthcare, que obtuvo un rendimiento del -13.6% el año pasado.

Rentabilidad vs. Mercado: FLRY3 obtuvo unos resultados inferiores a los del mercado BR, que fueron del -1.6% el año pasado.

Volatilidad de los precios

Is FLRY3's price volatile compared to industry and market?
FLRY3 volatility
FLRY3 Average Weekly Movement3.1%
Healthcare Industry Average Movement6.1%
Market Average Movement4.5%
10% most volatile stocks in BR Market8.5%
10% least volatile stocks in BR Market2.3%

Precio estable de las acciones: FLRY3 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de FLRY3 (3%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
192627,000Jeane Tsutsuiri.fleury.com.br

Fleury S.A., junto con sus filiales, presta servicios médicos en las áreas de diagnóstico, tratamiento, análisis clínicos, gestión sanitaria, asistencia médica, ortopedia y oftalmología en Brasil. La empresa opera a través de tres segmentos: Medicina Diagnóstica, Medicina Integrada y Odontología. Ofrece pruebas de laboratorio e imagen, genómica, gestión y plataforma de salud, información diagnóstica, laboratorio de chequeo y referencia, clínica de día, centro de infusión, ortopedia y oftalmología, pruebas de imagen dental y servicios de diagnóstico por imagen.

Resumen de fundamentos de Fleury S.A.

¿Cómo se comparan los beneficios e ingresos de Fleury con su capitalización de mercado?
Estadísticas fundamentales de FLRY3
Capitalización bursátilR$7.49b
Beneficios(TTM)R$613.53m
Ingresos (TTM)R$7.55b

12.0x

Ratio precio-beneficio (PE)

1.0x

Ratio precio-ventas (PS)

¿Está FLRY3 sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de FLRY3
IngresosR$7.55b
Coste de los ingresosR$5.46b
Beneficio brutoR$2.09b
Otros gastosR$1.48b
BeneficiosR$613.53m

Últimos beneficios comunicados

Sep 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)1.13
Margen bruto27.69%
Margen de beneficio neto8.13%
Ratio deuda/patrimonio71.2%

¿Cómo se ha desempeñado FLRY3 a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

4.3%

Rentabilidad actual por dividendo

13%

Ratio de pagos